|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02656 160 HEALTH
Nominal 
40.740 +0.600 (+1.495%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | (56,047) | (64,526) | (42,391) |
| Net Cash from / (used in) Investing Activities | -- | (12,826) | 2,694 | 3,271 |
| Net Cash from / (used in) Financing Activities | -- | 69,584 | 80,629 | (11,231) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 711 | 18,797 | (50,351) |
| Cash & Cash Equivalents at beginning of period | -- | 57,555 | 39,088 | 89,439 |
| Effect of Foreign Exchange Rate Changes | -- | 0 | (330) | 0 |
| Others | -- | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 58,266 | 57,555 | 39,088 |
| Remarks: | Real time quote last updated: 28/10/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -19,115 |
| %Change | -76.847% |
| EPS / (LPS) | RMB -0.065 |
| NBV Per Share (¥) | RMB -- |